nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Pruritus—Mometasone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Hyoscyamine—Tachycardia—Leflunomide—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Hyoscyamine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Hyoscyamine—Angioedema—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Hyoscyamine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Hyoscyamine—Abdominal pain—Captopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Hyoscyamine—Body temperature increased—Captopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Hyoscyamine—Oedema—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Hyoscyamine—Dry skin—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Nausea—Pentoxifylline—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Vertigo—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Hyoscyamine—Diarrhoea—Mometasone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Hyoscyamine—Hypokalaemia—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Hyoscyamine—Syncope—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Hyoscyamine—Shock—Mycophenolic acid—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Hyoscyamine—Hypotension—Leflunomide—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Hyoscyamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hyoscyamine—Palpitations—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hyoscyamine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hyoscyamine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Hyoscyamine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hyoscyamine—Insomnia—Leflunomide—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hyoscyamine—Abdominal distension—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hyoscyamine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Hyoscyamine—Chest pain—Lisinopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Hyoscyamine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Hyoscyamine—Anxiety—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Hyoscyamine—Dyspnoea—Leflunomide—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Hyoscyamine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Hyoscyamine—Lethargy—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Hyoscyamine—Dyspepsia—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hyoscyamine—Vomiting—Mometasone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hyoscyamine—Dry mouth—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Hyoscyamine—Feeling abnormal—Azathioprine—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Rash—Mometasone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Asthenia—Captopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Dermatitis—Mometasone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Osteoarthritis—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Confusional state—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Headache—Mometasone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Fatigue—Leflunomide—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Oedema—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Pruritus—Captopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Hyoscyamine—Pain—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Hyoscyamine—Constipation—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Hyoscyamine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Shock—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Tachycardia—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Abdominal pain—Azathioprine—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Body temperature increased—Azathioprine—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Diarrhoea—Captopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Irritability—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Nausea—Mometasone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Ataxia—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Pain—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Constipation—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hyoscyamine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Hyoscyamine—Hypotension—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Hyoscyamine—Dizziness—Captopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Hyoscyamine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hyoscyamine—Depression—Prednisone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hyoscyamine—Urticaria—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Hyoscyamine—Body temperature increased—Leflunomide—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Abdominal pain—Leflunomide—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Myocardial infarction—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Insomnia—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Hyoscyamine—Vomiting—Captopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Dyspnoea—Lisinopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Rash—Captopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Dermatitis—Captopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Somnolence—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Headache—Captopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Dyspepsia—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Fatigue—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Hyoscyamine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Hyoscyamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Hyoscyamine—Constipation—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Pain—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Bradycardia—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Hyoscyamine—Diarrhoea—Azathioprine—systemic scleroderma	0.000999	0.000999	CcSEcCtD
Hyoscyamine—Nausea—Captopril—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Hyoscyamine—Asthenia—Leflunomide—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Hyoscyamine—Hallucination—Prednisone—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Hyoscyamine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Hyoscyamine—Pruritus—Leflunomide—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Hyoscyamine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Hyoscyamine—Dizziness—Azathioprine—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Hyoscyamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Hyoscyamine—Diarrhoea—Leflunomide—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Hyoscyamine—Urticaria—Lisinopril—systemic scleroderma	0.000942	0.000942	CcSEcCtD
Hyoscyamine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Hyoscyamine—Abdominal pain—Lisinopril—systemic scleroderma	0.000937	0.000937	CcSEcCtD
Hyoscyamine—Body temperature increased—Lisinopril—systemic scleroderma	0.000937	0.000937	CcSEcCtD
Hyoscyamine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000931	0.000931	CcSEcCtD
Hyoscyamine—Vomiting—Azathioprine—systemic scleroderma	0.000929	0.000929	CcSEcCtD
Hyoscyamine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000926	0.000926	CcSEcCtD
Hyoscyamine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Hyoscyamine—Rash—Azathioprine—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Hyoscyamine—Dermatitis—Azathioprine—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Hyoscyamine—Flushing—Prednisone—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Hyoscyamine—Headache—Azathioprine—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Hyoscyamine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Hyoscyamine—Dizziness—Leflunomide—systemic scleroderma	0.000912	0.000912	CcSEcCtD
Hyoscyamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Hyoscyamine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Hyoscyamine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Hyoscyamine—Arrhythmia—Prednisone—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Hyoscyamine—Vomiting—Leflunomide—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Hyoscyamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Hyoscyamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Hyoscyamine—Rash—Leflunomide—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Hyoscyamine—Dermatitis—Leflunomide—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Hyoscyamine—Mental disorder—Prednisone—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Hyoscyamine—Nausea—Azathioprine—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Hyoscyamine—Headache—Leflunomide—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Hyoscyamine—Erythema—Prednisone—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Hyoscyamine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Hyoscyamine—Asthenia—Lisinopril—systemic scleroderma	0.00085	0.00085	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Hyoscyamine—Pruritus—Lisinopril—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Hyoscyamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Hyoscyamine—Rash—Mycophenolic acid—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Hyoscyamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Hyoscyamine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Hyoscyamine—Headache—Mycophenolic acid—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Hyoscyamine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Hyoscyamine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Hyoscyamine—Nausea—Leflunomide—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Hyoscyamine—Vision blurred—Prednisone—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Hyoscyamine—Diarrhoea—Lisinopril—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Hyoscyamine—Agitation—Prednisone—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Hyoscyamine—Angioedema—Prednisone—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Hyoscyamine—Dizziness—Lisinopril—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Hyoscyamine—Nausea—Mycophenolic acid—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Hyoscyamine—Vertigo—Prednisone—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Hyoscyamine—Syncope—Prednisone—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Hyoscyamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisone—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Hyoscyamine—Vomiting—Lisinopril—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Hyoscyamine—Rash—Lisinopril—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Hyoscyamine—Convulsion—Prednisone—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Hyoscyamine—Dermatitis—Lisinopril—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Hyoscyamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Hyoscyamine—Headache—Lisinopril—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Hyoscyamine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Hyoscyamine—Anxiety—Prednisone—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Hyoscyamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Hyoscyamine—Nausea—Lisinopril—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Hyoscyamine—Oedema—Prednisone—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Hyoscyamine—Shock—Prednisone—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisone—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Hyoscyamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Hyoscyamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Hyoscyamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Hyoscyamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Hyoscyamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Hyoscyamine—Insomnia—Prednisone—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Hyoscyamine—Dyspepsia—Prednisone—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Hyoscyamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Hyoscyamine—Fatigue—Prednisone—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Hyoscyamine—Constipation—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisone—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Hyoscyamine—Urticaria—Prednisone—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Hyoscyamine—Body temperature increased—Prednisone—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Hyoscyamine—Abdominal pain—Prednisone—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Hyoscyamine—Asthenia—Prednisone—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Hyoscyamine—Pruritus—Prednisone—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Hyoscyamine—Diarrhoea—Prednisone—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Hyoscyamine—Dizziness—Prednisone—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Hyoscyamine—Vomiting—Prednisone—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Hyoscyamine—Rash—Prednisone—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisone—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Hyoscyamine—Headache—Prednisone—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Hyoscyamine—Nausea—Prednisone—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—systemic scleroderma	0.000403	0.000403	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—systemic scleroderma	0.000369	0.000369	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—systemic scleroderma	0.000349	0.000349	CcSEcCtD
